when is semaglutide off patent With semaglutide's expiring, generics are set to enter from soon, setting competition in a fast-growing segment of obesity and diabetes care. https://timesofindia.indiatimes.com/toi-plus/business-economy/why-miracle-weight-loss-drugs-are Looming GLP-1 drug patent expirations

One looked at 16 patients with knee pain

Retrieved 3 October 2022

Canadian Employer Plans Covering GLP-1s for Weight Loss Have Nearly Doubled Data from the International Foundation of Employee Benefit Plans (IFEBP) 2025 Pulse Survey shows a significant shift in Canadian employer attitudes toward GLP-1 coverage: 31% of employer plans now cover GLP-1s for weight loss (up from 17% in 2024) 56% cover for diabetes only (down from 66% in 2024) 20% of diabetes-only plans are considering adding obesity coverage Provincial public drug plans still cover semaglutide only for type 2 diabetes not for weight loss

Your bulk supply remains more stable as lyophilized powder than as a solution

Develop coping strategies: Learn healthy ways to handle emotions without food

If you are on warfarin and start taking Bydureon BCise, your INR should be checked more often until it stabilizes, after which it can be monitored as usual